Kolexia
Dos Santos Melanie Oncologie médicale
Dos Santos Melanie
Oncologie médicale
Hôpital Côte de Nacre
Caen, France
63 Activités
49 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cystite Tumeurs colorectales Carcinomes Tumeurs de l'estomac Fatigue Néphrocarcinome Tumeurs de l'oesophage Tumeurs du sein Tumeurs du rein

Collaborateurs

Voir plus
Galais Marie-Pierre
Galais Marie-Pierre
Centre François-Baclesse, Caen, France
Parzy Aurelie
Parzy Aurelie
Centre François-Baclesse, Caen, France
Corbinais Stephane
Corbinais Stephane
Centre François-Baclesse, Caen, France
Joly Florence
Joly Florence
Hôpital Côte de Nacre, Caen, France

Industries

Voir plus
Servier
12 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2023
Leo Pharma
1 collaboration(s)
Dernière en 2022
MSD
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
iintune-1: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Essai Clinique (Takeda Pharmaceutical)   07 mars 2024
LBA30 Panitumumab (P) + FOLFIRINOX or mFOLFOX6 in unresectable metastatic colorectal cancer (mCRC) patients (pts) with RAS/BRAF wild-type (WT) tumor status from circulating DNA (cirDNA): First results of the randomised phase II PANIRINOX-UCGI28 study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1520P Perioperative treatment in resectable gastric cancer with spartalizumab combined with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): The GASPAR phase II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
9P Identification of a μCT-based radiomic signature of CD8+ tumour infiltrating lymphocytes in an orthotopic murine model
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
NEXT-REGIRI: A Randomized Phase III Trial Assessing a Regorafenib-irinotecan Combination (REGIRI) Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients After Failure of Standard Therapies, According to the A/A Genotype of Cyclin D1
Essai Clinique (Institut du Cancer de Montpellier)   26 septembre 2023
GASPAR: Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT): A Phase II Study (GASPAR)
Essai Clinique (Centre François-Baclesse)   22 décembre 2022
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe.
Critical reviews in oncology/hematology   17 octobre 2022
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
BMC cancer   12 mai 2022
Cognitive Impairment in Older Cancer Patients Treated with First-Line Chemotherapy.
Cancers   07 décembre 2021